Global Drugs for Short Bowel Syndrome Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Drugs for Short Bowel Syndrome Market Overview

• 1.1 Product Overview and Scope of Drugs for Short Bowel Syndrome
• 1.2 Classification of Drugs for Short Bowel Syndrome by Type
  • 1.2.1 Global Drugs for Short Bowel Syndrome Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Type in 2019
  • 1.2.3 GLP-2
  • 1.2.4 Growth Hormone
  • 1.2.5 Glutamine
  • 1.2.6 Other
• 1.3 Global Drugs for Short Bowel Syndrome Market by Application
  • 1.3.1 Overview: Global Drugs for Short Bowel Syndrome Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Global Drugs for Short Bowel Syndrome Market by Regions
  • 1.4.1 Global Drugs for Short Bowel Syndrome Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Drugs for Short Bowel Syndrome (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Ardelyx
  • 2.1.1 Ardelyx Details
  • 2.1.2 Ardelyx Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Ardelyx SWOT Analysis
  • 2.1.4 Ardelyx Product and Services
  • 2.1.5 Ardelyx Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Sancilio & Company
  • 2.2.1 Sancilio & Company Details
  • 2.2.2 Sancilio & Company Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Sancilio & Company SWOT Analysis
  • 2.2.4 Sancilio & Company Product and Services
  • 2.2.5 Sancilio & Company Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Merck
  • 2.3.1 Merck Details
  • 2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Merck SWOT Analysis
  • 2.3.4 Merck Product and Services
  • 2.3.5 Merck Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Emmaus Life Sciences
  • 2.4.1 Emmaus Life Sciences Details
  • 2.4.2 Emmaus Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Emmaus Life Sciences SWOT Analysis
  • 2.4.4 Emmaus Life Sciences Product and Services
  • 2.4.5 Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 OxThera
  • 2.5.1 OxThera Details
  • 2.5.2 OxThera Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 OxThera SWOT Analysis
  • 2.5.4 OxThera Product and Services
  • 2.5.5 OxThera Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 GLyPharma Therapeutic
  • 2.6.1 GLyPharma Therapeutic Details
  • 2.6.2 GLyPharma Therapeutic Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 GLyPharma Therapeutic SWOT Analysis
  • 2.6.4 GLyPharma Therapeutic Product and Services
  • 2.6.5 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Zealand Pharma
  • 2.7.1 Zealand Pharma Details
  • 2.7.2 Zealand Pharma Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Zealand Pharma SWOT Analysis
  • 2.7.4 Zealand Pharma Product and Services
  • 2.7.5 Zealand Pharma Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Nutrinia
  • 2.8.1 Nutrinia Details
  • 2.8.2 Nutrinia Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Nutrinia SWOT Analysis
  • 2.8.4 Nutrinia Product and Services
  • 2.8.5 Nutrinia Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Naia Pharmaceuticals
  • 2.9.1 Naia Pharmaceuticals Details
  • 2.9.2 Naia Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Naia Pharmaceuticals SWOT Analysis
  • 2.9.4 Naia Pharmaceuticals Product and Services
  • 2.9.5 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Takeda
  • 2.10.1 Takeda Details
  • 2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Takeda SWOT Analysis
  • 2.10.4 Takeda Product and Services
  • 2.10.5 Takeda Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Drugs for Short Bowel Syndrome Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Drugs for Short Bowel Syndrome Players Market Share
  • 3.2.2 Top 10 Drugs for Short Bowel Syndrome Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Drugs for Short Bowel Syndrome Revenue and Market Share by Regions
• 4.2 North America Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 4.3 Europe Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 4.5 South America Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)

5 North America Drugs for Short Bowel Syndrome Revenue by Countries

• 5.1 North America Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
• 5.2 USA Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 5.3 Canada Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)

6 Europe Drugs for Short Bowel Syndrome Revenue by Countries

• 6.1 Europe Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
• 6.2 Germany Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 6.3 UK Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 6.4 France Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 6.5 Russia Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 6.6 Italy Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Drugs for Short Bowel Syndrome Revenue by Countries

• 7.1 Asia-Pacific Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
• 7.2 China Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 7.3 Japan Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 7.4 Korea Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 7.5 India Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)

8 South America Drugs for Short Bowel Syndrome Revenue by Countries

• 8.1 South America Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
• 8.2 Brazil Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Drugs for Short Bowel Syndrome by Countries

• 9.1 Middle East & Africa Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 9.3 UAE Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Drugs for Short Bowel Syndrome Revenue and Market Share by Type (2015-2020)
• 10.2 Global Drugs for Short Bowel Syndrome Market Forecast by Type (2019-2024)
• 10.3 GLP-2 Revenue Growth Rate (2015-2025)
• 10.4 Growth Hormone Revenue Growth Rate (2015-2025)
• 10.5 Glutamine Revenue Growth Rate (2015-2025)
• 10.6 Other Revenue Growth Rate (2015-2025)

11 Global Drugs for Short Bowel Syndrome Market Segment by Application

• 11.1 Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2015-2020)
• 11.2 Drugs for Short Bowel Syndrome Market Forecast by Application (2019-2024)
• 11.3 Hospital Pharmacies Revenue Growth (2015-2020)
• 11.4 Retail Pharmacies Revenue Growth (2015-2020)
• 11.5 Online Pharmacies Revenue Growth (2015-2020)

12 Global Drugs for Short Bowel Syndrome Market Size Forecast (2021-2025)

• 12.1 Global Drugs for Short Bowel Syndrome Market Size Forecast (2021-2025)
• 12.2 Global Drugs for Short Bowel Syndrome Market Forecast by Regions (2021-2025)
• 12.3 North America Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
• 12.4 Europe Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
• 12.6 South America Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer